Ticker Symbol: PYPD
Polypid Ltd
$7.44 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001611842
Company Profile
PolyPid Ltd. is a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics. PolyPid’s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with medications, enables precise delivery of drugs at effective release rates, over durations ranging from several days to months. PolyPid’s lead product candidate D-PLEX100 is in Phase 3 clinical trials for the prevention of sternal and abdominal surgical site infections (SSIs).
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: N/A
Website: www.polypid.com
CEO: N/A
Tags:
- Health Technology
- Pharmaceuticals: Major
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $3.94
Change:
$0.08
(
2.07%)
Days Range: $3.92 - $4.08
Beta: -
52wk. High: $38.70
52wk. Low: $3.57
Ytd. Change -79.10%
50 Day Moving Average: $5.73
200 Day Moving Average: $10.00
Shares Outstanding: 19851833
Valuation
Market Cap: 7.8B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A